A5054240902- Amyloidosis: Diagnosis, Treatment, Outcomes
- Eosinophilic Disorders and Syndromes
- Chemotherapy-induced cardiotoxicity and mitigation
- Stress and Burnout Research
- Parathyroid Disorders and Treatments
- Aging, Health, and Disability
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Connective tissue disorders research
- Cardiac Valve Diseases and Treatments
- Cardiac Structural Anomalies and Repair
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- Sarcoidosis and Beryllium Toxicity Research
Hospital La Paz Institute for Health Research
2024
Hospital Base Guillermo Almenara Irigoyen
2023-2024
United States Naval Medical Research Unit SOUTH
2022
Universidad de San Martín de Porres
2018
Marfan´s syndrome is a multisystemic, autosomal dominant congenital abnormality of variable penetrance that affects the integrity connective tissue. In cardiovascular system, dysfunction physiology aortic root and myocardial fibrosis originates non-ischemic cardiomyopathy independent valve lesions. Few data have been reported on prevalence arrhythmias its impact heart function. We present 21-year-old man with Marfan's failure frequent supraventricular dilation. After ablation in...
Objective: To determine the association between exposure to scuba diving during military service and development of neurocognitive disorders in elderly people. Materials methods: A retrospective analytical study, derived from database analysis study "Fragility functional dependence older adults" conducted 2010 2015 on an outpatient basis by staff geriatrics Centro Médico Naval del Perú (Peruvian Medical Center). The chi-square test, p<0.05 95 % CI were used establish said association,...
Amyloidosis is a multisystem disease caused by infiltration of misfolded proteins; cardiac involvement determines its prognosis. There are several types precursor proteins capable causing the disease; however, only two affect heart, clonal immunoglobulin light chains (AL) and tetrameric transthyretin (TTR) protein. It an underdiagnosed and, in late stages, it has poor We present case older adult patient with progressive extracardiac manifestations, as well laboratory echocardiographic...
La amiloidosis cardíaca AL es una enfermedad por depósito extracelular de proteínas insolubles; sin tratamiento la supervivencia suele ser inferior a seis meses tras el inicio síntomas falla cardiaca. El esquema CYBORD-D primera elección su seguridad y evolución favorable. Presentamos caso un paciente con clínica disfunción extracardíaca severa, además todos los parámetros laboratoriales ecocardiográficos mal pronóstico. Al año seguimiento, ocho ciclos CYBORD, presentó gran mejoría clínica,...